Jefferies on United Therapeutics Corp. (UTHR): expecting '+15–25%' move following positive topline data
Tweet Send to a Friend
Jefferies analyst Roger Song reiterated a Buy rating and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
